Medical Xpress June 13, 2022
European Society of Human Genetics

Children who are born severely ill or who develop serious illness in the first few weeks of life are often difficult to diagnose, with considerable implications for their short and longer-term care. But whole genome sequencing (WGS), carried out rapidly, can provide an accurate diagnosis and therefore lead to improvements in their clinical care. Results from an Australian study of such a use of WGS presented to the annual conference of the European Society of Human Genetics on June 12 show how the integration of genomic, transcriptomic, and functional data can accelerate rare disease diagnosis on a national scale.

“The evidence of diagnostic, clinical, and family benefit of rapid genomic testing in critically ill children is overwhelming. This type of...

Today's Sponsors

Amwell
Oliver Wyman
Upfront Healthcare

Today's Sponsors

Qure4u
H1

Today's Sponsor

HealthITq

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Executive Interviews at Fierce Biotech Summit 2022
New AI precision medicine tool adopted by UCLA, Rush, other health systems
The American Heart Association Launches Precision Medicine Platform, New Proprietary Computational Models for Oncology Drug Discovery, More
Examining mRNA vaccine effectiveness for immunocompromised adults during omicron BA.4 and BA.5 predominance
Biotech's newest odd couple: A pharma insider and a music maven launch a health care VC